BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2015 8:49:00 AM | Browse: 1320 | Download: 1446
 |
Received |
|
2014-06-23 16:23 |
 |
Peer-Review Started |
|
2014-06-23 19:59 |
 |
To Make the First Decision |
|
2014-08-14 14:39 |
 |
Return for Revision |
|
2014-08-18 09:39 |
 |
Revised |
|
2014-11-15 00:00 |
 |
Second Decision |
|
2015-04-20 11:36 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2015-04-30 11:23 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2015-08-06 18:07 |
 |
Publish the Manuscript Online |
|
2015-08-20 08:49 |
ISSN |
2218-6204 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Hematology |
Manuscript Type |
Review |
Article Title |
European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jan Jacques Michiels, Fransje Valster, Jenne Wielenga, Katrien Schelfout and Hendrik De Raeve |
Funding Agency and Grant Number |
|
Corresponding Author |
Jan Jacques Michiels, MD, PhD, Investigator, Senior Internist, International Hematology and Bloodcoagulation Research Center, Goodheart Institute and Foundation in Nature Medicine, European Working Group on Myeloproliferative Neoplasms, Erasmus Tower, Veenmos 13, 3069 AT Rotterdam,
The Netherlands. goodheartcenter@upcmail.nl
|
Key Words |
Myeloproliferative disorders; Essential thrombocythemia; Primary megakaryocytic granulocytic myeloproliferation; Myelofibrosis; JAK2V617F mutation; MPL515 mutation; Calreticulin mutation; JAK2 wild type; Myeloproliferative neoplasm; Bone marrow pathology; Polycythemia vera |
Core Tip |
The 2015 World Health Organization-Clinical Molecular and Pathological criteria define three pheno-types of JAK2V617F mutated myeloproliferative neoplasms (MPNs) essential thrombocythemia (ET), prodromal polycythemia vera (PV), prodromal PV, hyper-cellular megakaryocytic-granulocytic myelo-proliferation and classical PV vs the JAK2 exon 12 mutated idiopathic eryhrocythemia and PV. MPL515 mutated JAK2 wild type ET and myelofibrosis is a distinct thrombocythemia without features of PV in blood and bone marrow. Calreticulin mutated JAK2/MPL wild type ET and myelofibrosis is the third thrombocythemia entity with characteristic features of primary megakaryocytic granulocytic myeloproliferation in the bone marrow, which are not seen in JAK2 and MPL mutated MPNs. MPN disease burden is best reflected by the degree of anemia and splenomegaly on top of mutation allele burden, bone marrow cellularity and increase of reticulin fibrosis.
|
Publish Date |
2015-08-20 08:49 |
Citation |
Michiels JJ, Valster F, Wielenga J, Schelfout K, De Raeve H. European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms. World J Hematol 2015; 4(3): 16-53 |
URL |
http://www.wjgnet.com/2218-6204/full/v4/i3/16.htm |
DOI |
http://dx.doi.org/10.5315/wjh.v4.i3.16 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345